Camlin Fine Sciences Limited has informed the Exchange about change in Management
CAMLINFINE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Camlin Fine Sciences Limited held a Board Meeting on May 26, 2026 approving audited financial results for Q4 and FY ended March 31, 2026. Standalone revenue from operations was Rs 18,351.65 lakh for Q4 and Rs 83,791.82 lakh for FY2026 (down from Rs 88,649.13 lakh in FY2025). The company reported a standalone loss before tax of Rs 5,409.22 lakh for FY2026. The auditors Kalyaniwalla & Mistry LLP issued unmodified opinions. Key management changes include appointment of Mr. Pankaj Pandey as new CFO effective August 18, 2026, with Mr. Santosh Parab ceasing to hold CFO role and being re-designated as President – Strategy and Global CFO. The 33rd AGM is scheduled for August 11, 2026.
The CFO transition represents a key management change. The company continues to face financial headwinds with declining standalone revenue and significant losses. However, the CFO transition appears to be an internal restructuring rather than a distress-related exit, as Mr. Parab remains with the company in a new role.